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Edited by Vladimir SkulachevAbstract As a natural anti-cancer alkaloid extracted from
Amaryllidaceae, lycorine shows various biological eﬀects on tu-
mor cells. The survival rate of HL-60 cells exposed to lycorine
was decreased in a dose-dependent manner with 1 lM as the
50% inhibitory concentration (IC50), cell growth was slowed
down by arresting cell cycle at G2/M phase, and cell regenera-
tion potential was inhibited. HL-60 cells exhibited typical apop-
totic morphological changes, apoptotic DNA ‘‘ladder’’ pattern,
and sub-G1 peak in cell phase distribution, showing apoptosis
of HL-60 cells. To further understand the apoptotic molecular
mechanism of lycorine on HL-60 cells, caspase activity was
tested by colorimetric assay, and the expression of Bcl-2 and
Bax proteins was examined by Western blotting. The increase
of caspase-8, -9, -3 activities demonstrated that caspase was a
key mediator of apoptotic pathways induced by lycorine. Un-
der-expression of Bcl-2 and increase of Bax:Bcl-2 ratio showed
that Bcl-2 family proteins were involved in apoptosis. Our ﬁnding
suggests that lycorine can suppress leukemia growth and reduce
cell survival via arresting cell cycle and inducing apoptosis of tu-
mor cells.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Apoptosis1. Introduction
Tumors are the diseases with proliferation disorder and
apoptosis obstacle. The inhibition of proliferation and
induction of apoptosis are regulated by a network of signal-
ing pathways and transcription factors, which are possible
targets for a rational tumor therapy [1,2]. For instance,Abbreviations: IC50, 50% inhibitory concentration; APL, acute
promyelocytic leukemia; DMSO, dimethyl sulfoxide; MTT, 3-(4,5-di-
methyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide; PBS, phos-
phate-buﬀered saline; AO, acridine orange; EB, ethidium bromide;
PI, propidum iodide; IETD-pNA, Ile-Glu-Thr-Asp conjugated to p-
nitroanilide; LEHD-pNA, Leu-Glu-His-Asp conjugated to p-nitroani-
lide; DEVD-pNA, Asp-Glu-Val-Asp conjugated to p-nitroanilide
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doi:10.1016/j.febslet.2004.10.095some anti-cancer reagents cause cell death through interfer-
ing with the processes of cell cycle [3] and some others cause
cell death by apoptosis [4,5], which plays an important role
in the balance between cell replication and cell death. Leuke-
mia, one of the most threatening hematological malignant
cancers today, has been found very sensitive to anti-cancer
chemotherapeutic reagents which either interfere with cell cy-
cles or cause apoptosis [6]. This chemical-reagent-sensitive
potential of leukemia intrigues scientists to look for more
speciﬁc and eﬀective chemical drugs against it. As a very
valuable source for novel chemotherapeutic reagents, natural
plant compounds exhibit eﬀective anti-tumor activities with
wide range of mechanisms. For example, artemisinin and
its derivatives mainly arrest cell cycle in G1 phase [7], while
paclitaxel was proved to possess anti-microtubule activity
and to arrest cell cycle at G2/M phase transition [8]. There-
fore, it becomes an important research target and has been
the aim of new drug design so as to ﬁnd novel anti-leukemia
chemotherapeutic medicines from natural products [9].
Lycorine is a natural alkaloid extracted from Amaryllida-
ceae. It showed various anti-tumor and anti-inﬂammatory
activities. The research results revealed that lycorine could in-
hibit protein synthesis in eukaryotic cells [10] and the acetyl-
cholinesterase enzyme [11]. Lycorine was also found to
inhibit protein synthesis and cell apoptosis of MM46 in the
presence of calprotectin [12]. However, the exact mechanism
of lycorine against leukemia remains unknown. Here, we use
human acute promyelocytic leukemia (APL) cell line HL-60,
which is widely used as a leukemia cell model to study the cel-
lular and molecular events, to investigate the molecular mech-
anism of lycorine against leukemia. In this study, we show that
lycorine can suppress leukemia cell growth and reduce cell sur-
vival via arresting cell cycle and inducing apoptosis of tumor
cells, which provides a new insight of lycorine serving as an
anti-leukemia reagent.2. Materials and methods
2.1. Cell culture and drugs
Human leukemia cell line HL-60 was purchased from American
Type Culture Collection, and was cultivated in RPMI 1640 medium
(Gibco) supplemented with 10% heat-inactivated fetal bovine serum
(FBS; Invitrogen), 100 kU/L benzylpenicillin, and 100 mg/L strepto-
mycin at 37 C in a humidiﬁed atmosphere with 5% CO2. Cells were
diluted at a ratio of 1:5 every 2–3 days. Lycorine (Latoxan, France)
was dissolved at 0.03 M in dimethyl sulfoxide (DMSO; Sigma) as ablished by Elsevier B.V. All rights reserved.
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fore use. The maximum ﬁnal concentration of DMSO in medium
was smaller than 0.02% (v/v).
2.2. Cell survival rate and cytotoxicity assay (MTT)
Cell survival rate and cytotoxicity were measured with 3-(4,5-di-
methyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide (MTT) assay as
described previously [13] with slight modiﬁcation. Brieﬂy, exponen-
tially growing HL-60 cells were seeded at 1 · 104 cells/well in a 96-well
tissue culture plate (BioCoat) with a total volume of 200 ll per well.
The lycorine concentrations ranging from 0 to 5 lMwere added imme-
diately. After cells were incubated for 24 h, the relative cell viability
was measured by scanning with an ELISA reader with a 570 nm ﬁlter
and the 50% inhibitory concentration (IC50) of lycorine on cells was
calculated by MTT assay.
2.3. Cell counting
In order to examine the anti-proliferative eﬀect of lycorine, growth
curves were protracted by a manual count method. Cells treated with
lycorine (1.25 lM) or without lycorine were seeded at 1 · 104 cells/well
in a 24-well tissue culture plate (BioCoat). After appropriate culture,
viable cells were counted up to 5 days continuously by the trypan blue
dye exclusion method.
2.4. Semisolid colony assay
HL-60 cells in the exponential growth phase were plated at 1.5 · 103
cells/well in a 24-well plate containing 2.5% methylcellulose, 10% FBS,
RPMI 1640 medium and lycorine at diﬀerent concentrations. After
incubation for 7–10 days, colonies more than 50 cells were counted un-
der an inverted microscope.
2.5. Fluorescence morphological examination
Cellular apoptotic morphological changes were studied by ﬂuores-
cence microscope. Cells were harvested and washed three times with
phosphate-buﬀered saline (PBS) after being incubated with diﬀerent
lycorine concentrations for 24 h, stained with 100 lg/ml acridine or-
ange and ethidium bromide (AO/EB; Sigma) for 5 min. Then, the types
of cells were observed according to the color and structure [14] under a
ﬂuorescence microscope (Olympus).
2.6. DNA fragmentation assay
DNA fragmentation was analyzed after the extraction of low-molec-
ular-weight DNA from cells, and 5 · 106 cells incubated with diﬀerent
lycorine concentrations or without lycorine for 24 h were harvested.
Total DNA was extracted according to the procedure of Sellins et al.
[15]. The DNA was separated on a 1.5% agarose gel and visualized un-
der UV light by EB staining.
2.7. Flow cytometry
Flow cytometry was used to detect quantitatively apoptotic rate
and the distribution of cell cycle. After being cultivated with med-
ium alone or medium containing lycorine (5 lM) at the indicated
time (0, 12, 24, and 36 h), 1 · 106 cells were harvested and washed
with PBS. Then, they were ﬁxed with ice-cold 70% ethanol at 4 C,
stained with 50 mg/ml propidium iodide (PI; Sigma), and dissolved
with 100 mg/L RNase A (Sigma). The sub-G1 peak (DNA content
less than 2 N) and cell cycle distribution were measured with FAC-
Scan Flow Cytometry (Becton–Dickinson) and analyzed by Cell
Quest software.Fig. 1. Lycorine decreases the survival rate of HL-60 cells and slows
down the cells growth. (A) Eﬀect of lycorine on the survival rate of
HL-60. Cells were cultivated in RPMI 1640 medium with indicated
concentrations of lycorine for 24 h. The cell survival rate was
calculated by MTT assay. (B) Eﬀect of lycorine on the growth curve
of HL-60. HL-60 cells were treated by 1.25 lM lycorine for indicated
days. The cell proliferation was estimated by trypan blue dye exclusion
method. Each value represents mean ± S.D. of three independent
experiments.2.8. Caspase activity assay
The cleavage activity of Ile-Glu-Thr-Asp conjugated to p-nitroani-
lide (IETD-pNA), Leu-Glu-His-Asp conjugated to p-nitroanilide
(LEHD-pNA), and Asp-Glu-Val-Asp conjugated to p-nitroanilide
(DEVD-pNA) was measured by using the FLICE/caspase-8, Mch6/
caspase-9, and CPP32/caspase-3 colorimetric assay kits (BioVision),
respectively. The recommended protocols were followed. Brieﬂy,
2 · 106 exponentially growing HL-60 cells in 5 ml were treated with
lycorine (5 lM) for 0, 6, 12, 18, and 24 h at 37 C. At the indicated
time points, cells were pelleted by centrifugation and resuspended in
50 ll chilled cell lysis buﬀer. The protein concentration was measured
by using a micro BCA kit (Pierce). Then, we diluted 100 lg proteinto 50 ll cell lysis buﬀer for each assay and 50 ll of 2 · reaction buﬀer
supplemented with 10 mM DTT was then added to each tube incu-
bated at 4 C. The substrates of IETD-pNA, LEHD-pNA, and
DEVD-pNA were added into the tubes (5 ll, 50 lM), respectively.
The formations of p-nitroanilide were measured by ELISA Micro-
plate Reader (Bio-tek) at 405 nm before the samples were incubated
for 1.5 h at 37 C. Percent increase in caspases activities was deter-
mined by comparing those results of the indicated time points with
controls.
2.9. Western blotting
2 · 106 exponentially growing HL-60 cells treated with lycorine at
the indicated concentrations for 24 h were pelleted by centrifuga-
tion, washed with PBS (3 ml) two times and resuspended in 100
ll of lysis buﬀer containing 20 mM HEPES, pH 7.4, 100 mM NaCl,
1% Nonidet P-40, 2% SDS, 1 mM EDTA, 1 mM EGTA, 1 mM so-
dium orthovanadate, 50 mM sodium ﬂuoride, 1 mM phenylmethyl-
sulfonyl ﬂuoride, 10 mg/ml leupeptin, and 1 mg/ml aprotinin, and
sonicated. Protein concentration in supernatant was measured by
using a micro BCA kit (Pierce). Protein (100 lg) was electrophore-
sed for 2 h on 12% SDS–polyacrylamide gels and then transferred
to polyvinylidene diﬂuoride membranes (Millipore) by using an elec-
troblotter for 12 h at 4 C. In all cases, antibodies (Santa Cruz Bio-
tech) raised against Bcl-2 or Bax (1:200) or a-tubulin (1:4000) were
diluted in PBST containing 5% non-fat milk and membranes were
incubated for 2 h with gentle agitation. The blots were washed
for three times (10 min each) with PBST and incubated with a sheep
anti-mouse conjugated to horseradish peroxidase (Santa Cruz Bio-
tech, 1:2000 dilution in PBST containing 5% non-fat milk) for 2
h. After three successive washes (10 min each) with PBST, Western
blotting chemiluminescence (ECL) reagent (Pierce) was used for
J. Liu et al. / FEBS Letters 578 (2004) 245–250 247detection. The optical density of the immunoradiograms was quan-
tiﬁed by densitometric scanning and data were analyzed by Sigma
Plot.
2.10. Statistical analysis
The statistical diﬀerence between the groups was determined by
AVOVA and Tukeys Studentized Range test. The level of P < 0.05
was considered to be statistically signiﬁcant.3. Results
3.1. Lycorine decreased the survival rate
MTT assays suggested that lycorine had some selective
anti-tumor eﬀects, the survival rate of HL-60 cells exposed
to lycorine (0–5 lM) for 24 h was reduced in a dose-depen-
dent manner, and the viability of cells was decreased from
100% to 18.95% (Fig. 1A). The concentration required to in-
hibit HL-60 cells growth by 50% (IC50) was approximately
1 lM. Because lycorine was shown as a moderate toxicTable 1
Colony formation of HL-60 cells after lycorine treatment
Lycorine (lM) No. of colonies (per 1.5 · 103 cells)
0 179 ± 27
0.31 96 ± 17\
0.63 25 ± 9\
1.25 3 ± 2\
2.5 0\
HL-60 cells in the exponential growth phase were plated in a 24-well
plate with indicated concentrations of lycorine. After incubation for 7–
10 days, colonies with more than 50 cells were counted under an in-
verted microscope. Values are means ± S.D. in triplicate cultures
(asterisk symbol indicates P < 0.05 (*) compared with the control
group).
Fig. 2. Lycorine increases the proportion of G2/M phase cells and
apoptotic rates of HL-60 cells. After being treated with lycorine (5 lM)
or without for indicated times, cells were harvested and washed with
PBS, ﬁxed with ice-cold 70% ethanol, stained with PI, and treated with
RNase A. DNA content and cell cycle distribution were measured by
ﬂow cytometry and analyzed by Cell Quest Software. (A) HL-60 cells
cultivated with lycorine (5 lM) exhibit a decrease in S phase cells
corresponding to an increase in G2/M phase cells. The percentage of
G2/M phase cells was increased gradually from 2.5% to 13.7% when
the induction time was persisted from 0 to 36 h. (B) 5 lM lycorine
causes a signiﬁcant increase of apoptotic rate of HL-60 cells from
6.09% to 54.2% in a time-dependent manner.
Fig. 3. Lycorine induces apoptotic morphological changes on HL-60 cells. After being treated with indicated concentrations of lycorine for 24 h, HL-
60 cells were harvested, washed with PBS, and stained with AO/EB (100 lg/ml). Cell morphology was observed under ﬂuorescence microscopy.
Green live cells show normal morphology in control (A); green early apoptotic cells show nuclear margination and chromatin condensation with 1.25
lM (B) or 2.5 lM (C) lycorine treatment. Orange later apoptotic cells show fragmented chromatin and apoptotic bodies after 5 lM lycorine
treatment (D) (·400).
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of other tumor and non-tumor cell lines, such as human
multiple myeloma cell line ARH-77, mouse ﬁbroblast cell
line NIH3T3, and human recombinant cell line HEK293.
We found that lycorine at the same concentration could de-
crease the survival rate of tumor cell lines, HL-60 and
ARH-77, more than that of non-tumor cell lines, NIH3T3
and HEK293, and HL-60 cell line was the most sensitive
one to lycorine (data not shown).
3.2. Anti-proliferation and cell cycle arrest of lycorine
Cell proliferation was signiﬁcantly inhibited by lycorine
(1.25 lM), examined by trypan blue dye exclusion method
(Fig. 1B). The density of lycorine-treated HL-60 cells de-
creased to one-third of that of the control after ﬁve days
treatment. In the semisolid culture, the number of colonies
decreased signiﬁcantly in a dose-dependent manner in exper-
imental groups (Table 1), suggesting that lycorine eﬀectively
reduced the malignancy and suppressed the regeneration po-
tential of tumor cells. Since HL-60 cell line was highly sen-
sitive to the anti-proliferation eﬀect of lycorine, we examined
whether lycorine could interfere with cell cycles using the
ﬂow cytometry. We found that after HL-60 cells were trea-
ted with 5 lM of lycorine, the percentage of cells at S phase
decreased, corresponding to an increase in the percentage of
cells at G2/M phase (from 2.5% to 13.7%) (Fig. 2A), indicat-
ing an arrest of cell cycle at G2/M phase by lycorine.
3.3. Occurrence of apoptosis induced by lycorine
We examined that lycorine induced apoptosis of HL-60 cells
through using the ﬂuorescence microscope after staining cells
with AO/EB. Green live cells with normal morphology were
observed in control group (Fig. 3A). Green early apoptotic
cells with nuclear margination and chromatin condensation
were observed after lycorine treatment at concentrations of
1.25 and 2.5 lM (Fig. 3B and C), while orange later apoptotic
cells with fragmented chromatin and apoptotic bodies were
seen after the treatment of lycorine at concentration of 5 lM
(Fig. 3D).
No DNA fragmentation was observed when lycorine was
applied at concentration of 1.25 lM, but when the lycorine
concentration was increased to 2.5 or 5 lM, an apoptotic
DNA ‘‘ladder’’ pattern was obviously observed (Fig. 4A).
Apoptotic rates increased from 6.09% to 54.2% in a time-
dependent manner after lycorine (5 lM) induction when cells
were tested by the ﬂow cytometry (Fig. 2B).Fig. 4. Lycorine induces apoptosis on HL-60 cells via activating
caspases pathways. (A) Inducing DNA fragmentation on HL-60 cells
by lycorine. After lycorine treatment, the cellular DNA was extracted,
dialyzed and separated on a 1.5% agarose gel and visualized under UV
light by EB staining. Lane 1: control; lanes 2–4: lycorine (1.25, 2.5, and
5 lM for 24 h, respectively). (B) Activation of caspase-8, caspase-9,
and caspase-3 by lycorine. HL-60 cells were incubated with lycorine (5
lM) for indicated time before the caspase-8 substrate IETD-pNA, or
caspase-9 substrate LEHD-pNA, or caspase-3 substrate DEVD-pNA
(50 mM) was added. Assay mixtures were incubated for 1.5 h at 37 C
followed by measurement of the absorbance at 405 nm. Percent
increase in caspases activities was determined by comparing those
results at the indicated time points with the level of uninduction.
Results are presented as means ± S.D. (three independent experi-
ments).3.4. Caspase activation
A remarkable activation of caspase-8, caspase-9, and cas-
pase-3 was recorded in lysates from cells treated with 5 lM lyc-
orine at diﬀerent time points (Fig. 4B), and caspase activation
persisted for more than 24 h. The activation of caspase-3 was
increased most signiﬁcantly.
3.5. Under-expression of Bcl-2 protein and increase in Bax:Bcl-2
ratio by lycorine
The eﬀect of lycorine on the expression of Bcl-2 and Bax
proteins was determined by immunoblot. a-tubulin was used
for normalization and veriﬁcation of protein loading. After
being normalized to a-tubulin, the expression of Bcl-2 was de-
creased signiﬁcantly in a dose-dependent manner, while Baxprotein level was increased slightly (Fig. 5A and B). The ratio
of Bax:Bcl-2 was dramatically increased in a dose-dependent
manner (Fig. 5C).4. Discussion
Cancer and many human diseases are cell cycle diseases. Cell
cycle coordination takes place mainly at G1/S and G2/M phase
transitions by a series of checkpoints. It has been shown that
Fig. 5. Eﬀect of lycorine on expression of Bcl-2 and Bax in HL-60
cells. Exponentially growing HL-60 cells were treated with indicated
concentrations of lycorine for 24 h, cell lysates were prepared and
protein level of Bcl-2 and Bax was determined by immunoblot analysis.
(A) The expression of Bcl-2 and Bax after lycorine induction. a-tubulin
was used for normalization and veriﬁcation of protein loading. Lane 1:
control; lanes 2–4: HL-60 cells were treated with 1.25, 2.5, or 5 lM
lycorine, respectively. (B) Quantitative Bcl-2 and Bax expression after
normalization to a-tubulin (n = 2 at each concentration point). The
expression of Bcl-2 was decreased signiﬁcantly, while Bax protein level
was increased slightly after lyrocine induction. (C) The Bax:Bcl-2 ratio
corresponding to indicated concentrations of lycorine. Compared to
control, the ratio of Bax:Bcl-2 was increased signiﬁcantly when 2.5 and
5.0 lM lycorine were applied. Values are means ± S.D. (asterisk
symbol indicates P < 0.05 (\) compared with the control group).
J. Liu et al. / FEBS Letters 578 (2004) 245–250 249the activities of many regulatory factors of checkpoints are lost
or arrested during the process of tumorigenesis [16], and found
that some anti-tumor reagents could restore the altered regula-
tory checkpoints [17]. Many anti-tumor reagents can arrest cell
cycle and then induce cell apoptosis [18,19]. Cell cycle arrest
may ensure that cells have time to repair the damages
[20,21], whereas apoptosis may eliminate the damaged cells
[22]. Our study demonstrated that lycorine had anti-tumor
eﬀect by arresting G2/M HL-60 cells and inducing cell
apoptosis.
The mechanisms of apoptosis involve in mainly two signal-
ing pathways, including mitochondrial pathway and cell death
receptor pathway. The key element in mitochondrial pathway
is the eﬄux of cytochrome c from mitochondria to cytosol,
where it subsequently forms a complex (apoptosome) with
Apaf-1 and caspase-9, leading to the activation of the cas-
pase-3 [23]. The cell death receptor pathway is characterized
by binding cell death ligands and cell death receptors, and sub-
sequently activates caspase-8 and caspase-3 [24,25]. It can beseen that caspases are always at the center of apoptotic
machinery. Several caspases are shown to be key executors
of apoptosis mediated by various anti-tumor drugs [26]. Our
study indicated that mitochondrial pathway and death recep-
tor signaling pathway were both involved in apoptosis induced
by lycorine.
The Bcl-2 family proteins that consist of anti-apoptotic and
pro-apoptotic members determine life-or-death of a cell [27].
Bcl-2 oncoprotein located on the outer mitochondrial mem-
brane is important for the suppression of apoptosis [28]. Bcl-
2 can stabilize the mitochondria permeability transition and
avoid the release of cytochrome c to prevent caspase activation
[29]. Upregulation of Bax together with the downregulation of
Bcl-2 and increase in the ratio of Bax:Bcl-2 could be seen dur-
ing apoptotic death [30]. Our ﬁndings suggest that these pro-
teins are involved in the intracellular pathway leading to
apoptotic death induced by lycorine. Furthermore, the down-
regulation of Bcl-2 would inevitably promote the activation of
caspase.
In conclusion, lycorine served as anti-cancer function, which
could arrest cell cycle at G2/M phase and induce apoptosis of
HL-60 cells. We further proved that apoptosis of HL-60 cells
was induced by decreasing the level of Bcl-2, increasing the ra-
tio of Bax:Bcl-2, and increasing the activation of caspase-8,
caspase-9, and caspase-3. Thus, our ﬁndings provide new in-
sights into the molecular mechanism of the anti-leukemia
activity of lycorine.Acknowledgment: This work was supported with the grants from the
National Natural Science Foundation of China (Nos. 39880021 and
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